The odyssey of marine pharmaceuticals: a current pipeline perspective
Alejandro M. S. Mayer1, Keith B. Glaser2,1, Carmen Cuevas3, Robert S. Jacobs4, William R. Kem5, R. Daniel Little6, J. Michael McIntosh7, David Newman8, Barbara C. M. Potts9, Dale E. Shuster10
1Department of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA
2Cancer Research, R47J-AP9, Abbott Laboratories, 100 Abbott Park Rd, Abbott Park, IL 60064-6121, USA
3Research and Development Director, R&D PharmaMar, Avda. de los Reyes, 1 P.I. La Mina Norte, 28770 Colmenar Viejo, Madrid, Spain
4Ecology, Evolution and Marine Biology, University of California at Santa Barbara, Santa Barbara, CA 93106-9610, USA
5Department of Pharmacology and Therapeutics, University of Florida College of Medicine, P.O. Box 100267, Gainesville, FL 32610-0267, USA
6Department of Chemistry and Biochemistry, University of California at Santa Barbara, Santa Barbara, CA 93106-9510, USA
7Department of Psychiatry, University of Utah, 257 S. 1400 E., Salt Lake City, UT 84112-0840, USA
8Natural Products Branch, National Cancer Institute, 1003 W. 7th Street, Suite 206, Frederick, MD 21701, USA
9Nereus Pharmaceuticals Inc., 10480 Wateridge Circle, San Diego, CA 92121, USA
10Oncology, Eisai, Inc., 300 Tice Blvd., Woodcliff Lake, NJ 07677, USA
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Trends in Pharmacological Sciences
Tập 31 Số 6
255-265
Thông tin tác giả